Pfizer expects Covid vaccine demand for years
World 09:50 PM - 2021-05-04.
Demand for Pfizer's Covid vaccine could bolster its revenues for years, the US drugs giant has said.
Pfizer said it was expecting "durable demand" for the vaccine, in a similar way to flu vaccines.
In the first three months of 2021, the vaccine generated revenues of $3.5bn (£2.5bn) as governments scrambled to try to contain the pandemic.
Revenue from the treatment is expected to hit $26bn this year - accounting for more than one third of Pfizer's sales.
The forecast is based on already-signed contracts for 1.6 billion vaccine doses to be delivered this year.
Pfizer said it expected to sign more deals this year, and was in supply talks with several countries for 2022 and beyond.
PUKmedia / BBC
More news
-
Iraqi President Emphasises Building Strong Relations with U.S.
12:46 PM - 2024-03-24 -
Barham Salih Joins Harvard as Senior Fellow
12:07 AM - 2024-03-24 -
Iraqi First Lady, Japanese Ambassador Discuss Humanitarian Cooperation
07:50 PM - 2024-03-23 -
PUK Strongly Condemns Moscow Terrorist Attack
02:12 PM - 2024-03-23
see more
President Bafel Arrives in Russia to meet Foreign Minister
10:02 PM - 2024-03-28
First Lady to Women Journalists: Women Should Support One Another
10:23 AM - 2024-03-28
Qubad Talabani: Our Primary Focus is Kurdistan Region's Budget & Salary Issues
08:45 PM - 2024-03-27
IHEC: Most of the Parties and Coalitions Have not Nominated Candidates
03:58 PM - 2024-03-26
Most read
-
President Bafel Arrives in Russia to meet Foreign Minister
News 10:02 PM - 2024-03-28 -
PUK President: PUK Upholds the Policy of Seeking Peaceful Solutions
News 12:14 AM - 2024-03-29